Ansofaxine hydrochloride enhanced the effect of immunotherapy with Anti-TNFR2 against CT26 tumors, which was attributable to the reduction in Treg quantity and the recovery of intra-tumor CD8+T cells function. The gene discussed is TNFRSF1B; the disease is neoplasm.